NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Curative Biotechnology Inc (PINK: CUBT)
CUBT Technical Analysis
5
As on 9th Jun 2023 CUBT STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Sell for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CUBTSTOCK Price
Open | 0.01 | Change | Price | % |
High | 0.02 | 1 Day | 0.01 | 100.00 |
Low | 0.01 | 1 Week | 0.01 | 100.00 |
Close | 0.02 | 1 Month | 0.00 | 0.00 |
Volume | N/A | 1 Year | -0.04 | -66.67 |
52 Week High 8.76 | 52 Week Low 0.01 |
PINK USA Most Active Stocks
CNNA | 0.01 | 0.00% |
AITX | 0.01 | 0.00% |
TXGE | 1826.91 | -1.55% |
CAVR | 0.01 | % |
ENZC | 0.05 | 25.00% |
OZSC | 0.01 | 0.00% |
DPLS | 0.01 | 0.00% |
WRFX | 0.01 | % |
AMXVF | 1.05 | 10.53% |
AABB | 0.03 | 0.00% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
CUBT Daily Charts |
CUBT Intraday Charts |
Whats New @ Bazaartrend |
CUBT Free Analysis |
|
CUBT Important Levels Intraday
RESISTANCE | 0.04 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
RESISTANCE | 0.03 |
SUPPORT | 0.01 |
SUPPORT | 0.01 |
SUPPORT | 0.01 |
SUPPORT | 0.00 |
CUBT Forecast May 2024
4th UP Forecast | 0.1 |
3rd UP Forecast | 0.07 |
2nd UP Forecast | 0.06 |
1st UP Forecast | 0.04 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | -0.02 |
3rd DOWN Forecast | -0.03 |
4th DOWN Forecast | -0.06 |
CUBT Weekly Forecast
4th UP Forecast | 0.06 |
3rd UP Forecast | 0.05 |
2nd UP Forecast | 0.04 |
1st UP Forecast | 0.03 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | 0.00 |
3rd DOWN Forecast | -0.01 |
4th DOWN Forecast | -0.02 |
CUBT Forecast2024
4th UP Forecast | 16.9 |
3rd UP Forecast | 11.49 |
2nd UP Forecast | 8.14 |
1st UP Forecast | 4.79 |
1st DOWN Forecast | -4.75 |
2nd DOWN Forecast | -8.1 |
3rd DOWN Forecast | -11.45 |
4th DOWN Forecast | -16.86 |
Curative Biotechnology Inc ( PINK USA Symbol : CUBT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CUBT Other Details
Segment | EQ | |
Market Capital | 55401744.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CUBT Address
CUBT Latest News
CUBT Business Profile
Curative Biotechnology, Inc., doing business as Connectyx, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida. Address: 1825 NW Corporate Boulevard, Boca Raton, FL, United States, 33431
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service